Home News National Eye Institute Data Shows AREDS2 Nutrient Formula Reduces AMD Risk

National Eye Institute Data Shows AREDS2 Nutrient Formula Reduces AMD Risk

 Results provide new evidence of the recommended formula determined in the AREDS2 study

Patients may not be getting the nutrients they need from their diets alone.

Bausch + Lomb announced new data from the National Eye Institute (NEI) 10-Year Follow-on Study Results of the Age-Related Eye Disease Study 2 (AREDS2), which reaffirms the clinical outcomes of the AREDS2 study. Based on this data, the NEI continues to recommend a specific nutrient formula to help reduce the risk of progression in patients with moderate to advanced Age-Related Macular Degeneration (AMD).1 That formula is currently found in Bausch + Lomb PreserVision® AREDS 2 Formula eye vitamins, which was provided to participants in the last five years of the follow-on study. The study results were presented at the Association for Research in Vision and Ophthalmology annual meeting on May 7, 2021.

“These new, longer-term results from the NEI build on the findings of previous AREDS studies, which show that a precise mix and dosage of specific vitamins, minerals and antioxidants can help reduce the risk of progression in people who have moderate to advanced AMD,” said Rishi P. Singh, MD, professor of ophthalmology, Lerner College of Medicine, and staff surgeon at the Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio. “These findings further clarify the importance of an AREDS2 supplement as part of a patient’s plan, and the need for eye care professionals to provide a specific recommendation for this formulation in appropriate patients.”

The NEI’s 10-Year Follow-on Study of AREDS2 analysis included 3,887 people (6,360 study eyes) with intermediate to advanced AMD over a 10 year period. The study further validated the original findings about the AREDS2 formulation with 80mg of zinc and provided support for the continued benefit of lutein and zeaxanthin, which were shown to have an incremental beneficial effect as compared to beta-carotene.1

“For more than 20 years, Bausch + Lomb has been collaborating with researchers at the NEI to help eye care professionals and the 11 million Americans who are impacted by moderate to advanced AMD,” said Joe Gordon, U.S. president, Bausch + Lomb. “Since 2001, we have offered a portfolio of eye vitamins based on the most current, available science, and this data further supports the current formulation in our PreserVision® AREDS2 Formula eye vitamins.”

For more information on PreserVision® AREDS 2 formula eye vitamins, visit www.preservision.com.

References

  1. The Results of the 10 Year Follow-on Study of the Age-Related Eye Disease Study 2 (AREDS2); Emily Y. Chew, Traci E. Clemons, Tiarnan D. Keenan, Elvira Agron, Claire E. Malley, Amitha Domalpally.
- Advertisment -

Most Popular

Dr. Caitlin Reghetti: Supporting Patient Education With a Great Design

On her LinkedIn page, Caitlin Reghetti, OD, calls herself an ocular health literacy designer. It's a specialized role that brings together her interests in...

WO Board Perspectives: How to Stay Organized

In a world where we all wear many hats-- doctor, parent, spouse, child, friend, mentor and more-- staying organized can feel nearly impossible. The...

Advocates for Optometry on Capitol Hill

More than 500 optometrists and students gathered for the American Optometric Association’s AOA on the Hill on April 15 and 16 to advocate for...

Myopia Awareness Week 2024 Website Launches

Myopia Awareness Week 2024 is set for May 13-19, and Review of Myopia Management and BHVI have officially launched the website for the week-long...